Drug Discovery and Development Company Eikon Therapeutics Secures $350.7M

HAYWARD, Calif., Feb. 27, 2025 — Biotechnology company Eikon Therapeutics has closed a $350.7 million series D funding round. The company’s drug …

Continue

Do you trust this headline?

Based on recent headline ratings, 90% of this readership currently trusts the local media, which has an average score of 84% regionally and is currently trending negative.

90%

Media Trust Score

Read All

In

News